Search

Your search keyword '"Bertherat, Jerome"' showing total 71 results

Search Constraints

Start Over You searched for: Author "Bertherat, Jerome" Remove constraint Author: "Bertherat, Jerome" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
71 results on '"Bertherat, Jerome"'

Search Results

4. Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial

6. The experience of diagnosis announcement in rare endocrine diseases: A survey of the French FIRENDO network

7. Position statement on the diagnosis and management of acromegaly: The French National Diagnosis and Treatment Protocol (NDTP)

8. Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study

9. Recommandations du réseau national ENDOCAN-COMETE pour la prise en charge des phéochromocytomes et paragangliomes métastatiques

10. Recommandations conjointes du réseau National ENDOCAN-COMETE, de l’Association francophone de chirurgie endocrinienne et de la Société française d’urologie pour la prise en charge du carcinome corticosurrénalien

12. Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndrome

13. Consensus on diagnosis and management of Cushing's disease: a guideline update

16. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study

19. Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions

20. SFE/SFEDP adrenal insufficiency French consensus: Introduction and handbook

22. Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation

24. Corticosurrénalome et grossesse

25. Evidence of Persistent Mild Hypercortisolism in Patients Medically Treated for Cushing Disease: the Haircush Study.

26. SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)

27. SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma

28. Clinical Biology of the Pituitary Adenoma.

31. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis

33. Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation

37. SNP arrays in heterogeneous tissue: highly accurate collection of both germline and somatic genetic information from unpaired single tumor samples

39. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD

40. Frequent Phosphodiesterase 11A Gene (PDE11A) Defects in Patients with Carney Complex (CNC) Caused by PRKAR1A Mutations: PDE11A May Contribute to Adrenal and Testicular Tumors in CNC as a Modifier of the Phenotype

41. Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study

43. Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort study.

45. ARMC5 variants in PRKAR1A-mutated patients modify cortisol levels and Cushing's syndrome.

46. The ARMC5 gene shows extensive genetic variance in primary macronodular adrenocortical hyperplasia.

47. A rare case of familial Cushing's syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease.

48. Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad.

49. Differential Expression of Parathyroid Hormone-Related Protein in Adrenocortical Tumors: Autocrine/Paracrine Effects on the Growth and Signaling Pathways in H295R Cells.

Catalog

Books, media, physical & digital resources